Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
46.22
-1.24 (-2.61%)
At close: Sep 25, 2025, 3:59 PM
46.01
-0.45%
After-hours: Sep 25, 2025, 05:18 PM EDT
-2.61% (1D)
| Bid | 46.16 |
| Market Cap | 3.7B |
| Revenue (ttm) | 4K |
| Net Income (ttm) | -283.96M |
| EPS (ttm) | -3.81 |
| PE Ratio (ttm) | -12.13 |
| Forward PE | -11.34 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 46.41 |
| Volume | 691,533 |
| Avg. Volume (20D) | 1,131,358 |
| Open | 47.32 |
| Previous Close | 47.46 |
| Day's Range | 46.18 - 47.32 |
| 52-Week Range | 21.34 - 58.40 |
| Beta | -0.24 |
| Ex-Dividend Date | n/a |
About AKRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AKRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AKRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+97.52%
Akero Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
